Reliant Pharmaceuticals

Nathalie Moll, currently secretary general of the European Association for Bioindustries,has been appointed EFPIA's director general – effective April, 2017. Eric Cornut will continue to lead EFPI

A federal whistleblower lawsuit on service fees is the latest indication that drug manufacturers must carefully negotiate a complicated set of issues in calculating average manufacturer prices for rep

Amarin Corp. PLC ’s decision to delay the launch of its just-approved purified fish oil Vascepa by six months for unclear reasons raises questions about the product’s commercial potential and the c

Despite the uncertain pace of economic recovery, the aesthetics market has a distinct advantage over other fields: the public’s seemingly insatiable quest for youth. Although the struggling economy ha